SCHEMBL23914347

SCHEMBL23914347

C=C1C(=O)O[C@H](c2ccccc2)[C@@H]1c1ccccc1Br

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTR2C P28335 4/20 0.33
HTR2B P41595 4/20 0.33
BRD4 O60885 1/20 0.33
GID4 Q8IVV7 1/20 0.33
EDNRA P25101 1/20 0.33
SIRT1 Q96EB6 4/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SLC6A2 P23975 2/20 0.32
HTR2A P28223 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 1/20 0.32
KDM1A O60341 1/20 0.32
CA2 P00918 1/20 0.31
EGFR P00533 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914374 0.84 EDNRA (0.42) ALDH1A1GID4EDNRANPC1RAB9A
SCHEMBL23914438 0.81 MEN1 (0.43) ALDH1A1CYP2C9CYP2C19GID4NPC1
SCHEMBL23914451 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL5442142 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL14427618 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL23914452 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL23913983 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL23913984 0.81 SMN1; SMN2 (0.39) ALDH1A1CYP2C9CYP2C19HTR2BEDNRA
SCHEMBL23914399 0.78 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP2C19NPC1RAB9A
SCHEMBL23914400 0.78 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP2C19NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM HDAC4 1439/4885ALDH1A1 2164/4885CYP2C9 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.